NCT06597227 2024-09-19
TJHGC01
Tongji Hospital
Phase 4 Recruiting
Clinical Trials
11 trialsNCT06277453 2024-02-26
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
Fujian Medical University
Unknown
NCT06235164 2024-01-31
The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer
Fujian Medical University
Unknown
NCT05610332 2022-11-09
Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes
Fujian Medical University
Phase 3 Not yet recruiting
NCT05545436 2022-09-22
Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
NCT05528367 2022-09-06
Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT05524974 2022-09-01
Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes
Fujian Medical University
Phase 2 Not yet recruiting
NCT05141747 2022-02-23
A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.
Shanghai Miracogen Inc.
Phase 2 Unknown
NCT04792515 2021-03-11
CCWSA/OAFLAG
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Unknown
NCT03961373 2019-05-23
Neo-D2plus
University of Siena
Phase 3 Recruiting
NCT02192983 2015-12-03
A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.
Shanghai Zhongshan Hospital
Completed